Yutaka’s ongoing research project focuses on diet, gut microbiome and exercise to minimize the psychological burdens (fear of cancer recurrence, anxiety and depression) and to enhance the quality of survival for all people diagnosed with cancer along with their family caregivers. His research goal is to develop and disseminate evidence-based preventive mental health approach for physically ill patients as well as general population.
Scott is experienced in a range of study types. His expertise is nutrition and lifestyle research in the field of mental health. His research program spans observational studies, non-randomised controlled trials, qualitative research, and systematic reviews and meta-analysis. Scott has a strong translational research background. He was the pioneer clinical dietitian and led the nutrition research for six years within a successful lifestyle program for people with severe mental illness at high risk for cardiometabolic disease and premature mortality. During this time his research program advocated a clear role for dietitians in mental health services. Scott continues to have a passion for the role nutrition plays in brain health and cognition, mental wellbeing and mental disorders.
As depression is heterogenous and every antidepressant treatment only has modest effect, we colleagues at the Mind-Body Interface Laboratory (MBI-Lab) explore novel treatments and unknown biological mechanisms for depression
Zoltan’s research aims to find effective and safe biological treatment (e.g. therapeutic diets) suitable for the treatment of psychosis and depression, using animal models and translational approaches.
I’m interested in the role of Omega-3 fatty acids in mood disorders,
from a clinical staging perspective
He has a particular interest in anxiety and mood disorder research pertaining to integrative medicine, nutraceutical psychopharmacology and psychotropic plant medicines, and lifestyle medicine. His research also utilises genomic technology to examine the pharmacogenomics of individual responses to nutraceuticals in the treatment of psychiatric disorders. He is currently involved in over a dozen clinical trials in the area of mental health. Jerome is a founding Vice Chair of The International Network of Integrative Mental Health & an Executive Committee Member of the ISNPR
Coordinator and principal investigator of several research projects sponsored by the Spanish Ministry of Health (FIS PI042241, FIS PI080819, FIS PI1601274), she is an expert in Mediterranean diet and in the analyses of dietary patterns and life-style factors and their role in depression risk in observational studies. She has also implicated in the analysis of diet and depression in Spanish large clinical trials (PREMIMED, PREDIMED-PLUS, PREDI-DEP).
Her research focuses on micronutrient supplementation in populations with ADHD, mood issues, and aggression. She leads the Science of Nutrition Affect and Cognition in Kids (SNACK) Lab at OHSU. Dr. Johnstone is leading the Micronutrients in ADHD Youth, the “MADDY” Study, a three-site, international, randomized controlled trial for children who have ADHD and irritable mood. Through an examination of participant biological samples, she and her collaborators are examining the micronutrients’ biological signature, and potential mechanisms of action.
She is also honorary researcher at University College London in the Dept of Epidemiology and Public Health, working on the Whitehall II cohort. Specialising in nutritional epidemiology, Tasnime’s work aims to understand the role of diet in age-related chronic diseases and mental health by paying a special interest to the social gradient underlying dietary behavior and by investigating the biological and metabolic pathways through which overall diet is likely to influence mental and cognitive health. Currently she is also developing a research program on the role of diet in Autism Spectrum Disorders.